Blue Horseshoe Stocks: VTVT New Highs & More

vTv Therapeutics, Inc. VTVT

We’ve been closely tracking VTVT since including it our report on Tuesday morning as a bottom play. As we mentioned yesterday, the timing was essentially perfect. It took off on Tuesday, and yesterday that run persisted just as we suggested it may.

The stock traded in a range from 1.24 to a new high of 2.67 yesterday, representing an intraday move of 115% From Tuesday’s low of .79 the stock has registered a two-day upswing of 238% and has easily been the NASDAQ’s top play of the week.


Onconova Therapeutics, Inc. ONTX

Speaking of bottom plays, we’re always searching for the next heavily oversold stock, and we’ve got a candidate to bring forth today in ONTX. As you can plainly view on the chart snapshot below, the stock has been heavily sold off, and the RSI is definitely giving off that heavily oversold signal.

The last time that happened the stock did mount an appreciable recovery in the ensuing weeks, so we’re going to put ONTX on extended watch.


Extended Watchlist:
AXXA, IMTV, HMNY, AREX, AYTU, IRBT, AVGR

Incoming search terms:

  • 0ZQK
  • 9C7R
  • salmonh3k
  • strongercu7

Blue Horseshoe Stocks: USRM, TSLA Updates & More

U.S. Stem Cell, Inc. USRM

On Wednesday morning, we followed up with USRM after tracking it over a 289% rip subsequent to our alert on the play on February 27th. The stock had come down quite a bit off of those highs, and started to take on the appearance of a possible bottom-play. We mentioned the need to “return to monitoring this play more closely on the chance that it could be gearing up for another run.

It did find its bottom and it most certainly was gearing up for another run, which took up the entirety of yesterday’s session. The stock traded in a range from .0181 to .03, for a solid intraday rip of 66%, nearly all of which was held into a strong close .0289.

That type of blatantly bullish activity warrants continued close observation of USRM as we close out the week.


Tesla, Inc. TSLA – Options Update

Just yesterday, we identified TSLA as being ripe for a recovery, citing the TSLA 04/07 $270-277.50 Calls as our targets of interest. It was another solid options trading idea for us, with every single set of contracts in the range providing opportunities for solid single-session gains.

$270 Calls – Range: 3.37-6.65 – Max Gain: 97%
$272.50 Calls – Range: 2.77-5.35 – Max Gain: 93%
$275 Calls – Range: 2.52-4.70 – Max Gain: 87%
$277.50 Calls – Range: 1.93-3.85 – Max Gain: 99%

We also could see more bullish activity out of these plays, which we chose to hopefully take advantage of a more extended-term recovery for TSLA.

_____

Fresh Options Ideas:

We’re  looking to ABDE on the heels of an earnings neat, and will be after some potential quick-strike gains out of the ADBE Weekly $125 and $130 Calls*.

After trending down a bit over the past week, SNAP has received an analyst downgrade, so we’ll want to radar the SNAP Weekly $20 Puts* today for potential intraday swing trades.

*DO NOT trade weekly options on a Friday unless you’re a highly experienced trader!


Extended Watchlist:
POTN, SFOR, ICNB, AREX, ZFGN, BPMX,